Fitzsimon_menu

Filter by

Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision
News | Aug 24, 2023

Fitzsimons Innovation Community and Aimco Deepen Co-Commitment to Campus Vision

The new partnership will accelerate delivery of lab space to market. Designed for quick expansion and flexibility to respond to market needs, the development will begin with the 230,000-square-foot Bioscience 4 facility. Bioscience 4 will be the perfect space for health innovators on the frontlines of the most exciting progress in healthcare.

Gates Institute Anchors a Thriving Cell and Gene Therapy Hub in Colorado
News | Jun 12, 2023

Gates Institute Anchors a Thriving Cell and Gene Therapy Hub in Colorado

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development
News | May 24, 2023

Nusano and PharmaLogic Announce Collaboration to Enable Next Generation Radiotherapeutics Development

Colorado Real Estate Journal features perspective from April Giles on what drives momentum for life sciences in our state.
News | Apr 25, 2023

Colorado Real Estate Journal features perspective from April Giles on what drives momentum for life sciences in our state.

The Benson Hotel and Faculty Club Slated to Open in April
News | Apr 25, 2023

The Benson Hotel and Faculty Club Slated to Open in April

PharmaLogic Announces Collaboration With Perspective Therapeutics
News | Apr 25, 2023

PharmaLogic Announces Collaboration With Perspective Therapeutics

Gates Grubstake Fund Awards Over $1.5 Million to Campus Researchers
News | Apr 25, 2023

Gates Grubstake Fund Awards Over $1.5 Million to Campus Researchers

Gates Institute Pushing CU Anschutz to the Forefront in Cell Therapy
News | Apr 25, 2023

Gates Institute Pushing CU Anschutz to the Forefront in Cell Therapy

Colorado BioScience Association Releases 2023 Peak Talent Report
News | Apr 25, 2023

Colorado BioScience Association Releases 2023 Peak Talent Report

Atara Biotherapeutics Named one of BioSpace's top Neurodegenerative Readouts of 2023
News | Apr 20, 2023

Atara Biotherapeutics Named one of BioSpace's top Neurodegenerative Readouts of 2023

Foresight Diagnostics' PhasED-Seq Liquid Biopsy Approach Successfully Detects ctDNA in Majority of Patients: Study Shows Promise in Solid Tumor Recurrence Test
News | Apr 20, 2023

Foresight Diagnostics' PhasED-Seq Liquid Biopsy Approach Successfully Detects ctDNA in Majority of Patients: Study Shows Promise in Solid Tumor Recurrence Test

OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer
News | Mar 30, 2023

OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer